Axogen Inc vs Futu Holdings Ltd — how do they compare? Axogen Inc trades at $38.7 (market cap $2.06B), while Futu Holdings Ltd trades at $99.3 (market cap $13.76B). The key difference: Futu Holdings Ltd is far larger — about 6.7× Axogen Inc's market cap, and Futu Holdings Ltd pays a 2.65% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | FUTU | |
|---|---|---|
Market Cap | $2.06B | $13.76B |
Sector | Technology | Financials |
52-Week High | $46.19 | $199.04 |
52-Week Low | $11.28 | $89.76 |
Enterprise Value | $1.98B | $13.62B |
Dividend Yield | — | 2.65% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Futu Holdings trades at $96.35, showing minimal daily movement. The stock faces a bearish technical signal with support near $95 and resistance at $97. Fundamentally, the company reported strong 2025 revenue of $22.85 billion and net income of $11.34 billion, with a robust net margin of 41.83%. However, recent earnings misses and a class action lawsuit alleging securities fraud have created significant headwinds.
The outlook is clouded by legal risks and inconsistent earnings performance, despite attractive valuation ratios like a P/E of 10.65. Analyst consensus remains cautiously optimistic with a majority 'Buy' rating, but investors must weigh solid profitability against substantial regulatory and litigation overhangs that could pressure the stock in the near term.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →